Utility and limitations of ejection fraction and of diastolic dysfunction in heart failure patients

被引:4
作者
Mureddu, Gian Francesco [1 ]
Faggiano, Andrea [2 ]
机构
[1] San Giovanni Addolorata Hosp, Dept Internal Med, Cardiac Rehabil & Secondary Cardiovasc Prevent Un, Cardiol Unit 2, Rome, Italy
[2] Univ Milan, Milan, Italy
关键词
Ejection fraction (EF); heart failure (HF); diastolic dysfunction; preserved EF; mid-range EF; LEFT-VENTRICULAR DYSFUNCTION; SYSTOLIC DYSFUNCTION; CARDIOVASCULAR RISK; FOLLOW-UP; STAGE B; MORTALITY; POPULATION; ENALAPRIL; SURVIVAL; PREDICTOR;
D O I
10.4081/monaldi.2019.1058
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The echocardiographic evaluation of left ventricular (LV) systolic function, and especially of ejection fraction (EF) plays a central role in the diagnosis of heart failure (HF) due to its undisputed prognostic value. Limitations of EF are substantially: i) the variability and reproducibility of measurements, and ii) the load-dependence. Measurement of stroke volume, longitudinal function and myocardial strain can overcome the limitations of EF in assessing the contractile reserve of patients with HF and may help to define both the phenotype and prognosis of the disease. The recognition of diastolic dysfunction (mainly by echocardiography) is the pathophysiological basis to make diagnosis of HF with preserved ejection fraction (HFpEF). The limitations are essentially related to its feasibility, since performing a multi-parametric quantitative echocardiographic evaluation, as indicated by the guidelines, may be difficult in clinical practice. Difficulties in method standardization, the poor attitude of cardiologists to test their reproducibility (test-retest, variability) favor the evaluation "at-a-glance" of LV structural and functional LV abnormalities.
引用
收藏
页码:79 / 82
页数:4
相关论文
共 50 条
  • [41] Effect of Mineralocorticoid Receptor Antagonists on Cardiac Structure and Function in Patients With Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: A Meta-Analysis and Systematic Review
    Pandey, Ambarish
    Garg, Sushil
    Matulevicius, Susan A.
    Shah, Amil M.
    Garg, Jalaj
    Drazner, Mark H.
    Amin, Alpesh
    Berry, Jarett D.
    Marwick, Thomas H.
    Marso, Steven P.
    de Lemos, James A.
    Kumbhani, Dharam J.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2015, 4 (10):
  • [42] Diastolic heart failure in elderly: The prognostic factors and interventions regarding heart failure with preserved ejection fraction
    Acikel, Sadik
    Akdemir, Ramazan
    Kilic, Harun
    Yesilay, Asuman Bicer
    Dogan, Mehmet
    Cagirci, Goksel
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 138 (03) : 311 - 313
  • [43] Heart failure with recovered ejection fraction and the utility of defibrillator therapy: a review
    Devgun, Jasneet K.
    Kennedy, Samuel
    Slivnick, Jeremy
    Garrett, Zachary
    Dodd, Katherine
    Derbala, Mohamed H.
    Ortiz, Cristina
    Smith, Sakima A.
    ESC HEART FAILURE, 2022, 9 (01): : 1 - 10
  • [44] Incidence of chronic heart failure with preserved left ventricular ejection fraction in patients with hypertension and isolated mild diastolic dysfunction
    Brzyzkiewicz, Halina
    Konduracka, Ewa
    Gajos, Grzegorz
    Janion, Marianna
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2016, 126 (1-2): : 12 - 18
  • [45] Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients
    Cautela, Jennifer
    Tartiere, Jean-Michel
    Cohen-Solal, Alain
    Bellemain-Appaix, Anne
    Theron, Alexis
    Tibi, Thierry
    Januzzi, James L., Jr.
    Roubille, Francois
    Girerd, Nicolas
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (08) : 1357 - 1365
  • [46] Renal Dysfunction and Heart Failure with Preserved Ejection Fraction
    Ananthram, Manjula G.
    Gottlieb, Stephen S.
    HEART FAILURE CLINICS, 2021, 17 (03) : 357 - 367
  • [47] Diastolic dysfunction and heart failure with preserved ejection fraction: rationale for RAAS antagonist/CCB combination therapy
    Gaddam, Krishna K.
    Oparil, Suzanne
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2009, 3 (01) : 52 - 68
  • [48] Hormonal deficiencies in heart failure with preserved ejection fraction: prevalence and impact on diastolic dysfunction: a pilot study
    Favuzzi, A. M. R.
    Venuti, A.
    Bruno, C.
    Nicolazzi, M. A.
    Fuorlo, M.
    Dajko, M.
    De Waure, C.
    Landolfi, R.
    Mancini, A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (01) : 352 - 361
  • [49] Insights into foundational therapies for heart failure with reduced ejection fraction
    McMurray, John J. V.
    Docherty, Kieran F.
    CLINICAL CARDIOLOGY, 2022, 45 : S26 - S30
  • [50] Spironolactone in patients with heart failure and preserved ejection fraction
    Sanchez-Sanchez, C.
    Mendoza-Ruiz de Zuazu, H. F.
    Formiga, F.
    Manzano, L.
    Ceresuela, L. M.
    Carrera-Izquierdo, M.
    Gonzalez Franco, A.
    Epelde-Gonzalo, F.
    Cerqueiro-Gonzalez, J. M.
    Montero-Perez-Barquero, M.
    REVISTA CLINICA ESPANOLA, 2015, 215 (06): : 301 - 307